{"context":{"query":">>uniprot>>reactome","source_dataset":"uniprot","target_dataset":"reactome"},"stats":{"queried":6,"total":97,"mapped":6},"pagination":{"has_next":false},"schema":"id|name|tax_id|is_disease_pathway","mappings":[{"input":"O14746","source":"O14746|Telomerase reverse transcriptase","targets":["R-HSA-171319|Telomere Extension By Telomerase|9606|false","R-HSA-201722|Formation of the beta-catenin:TCF transactivating complex|9606|false","R-HSA-9825895|Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence|9606|false"]},{"input":"P84022","source":"P84022|SMAD family member 3","targets":["R-HSA-1181150|Signaling by NODAL|9606|false","R-HSA-1502540|Signaling by Activin|9606|false","R-HSA-2173788|Downregulation of TGF-beta receptor signaling|9606|false","R-HSA-2173789|TGF-beta receptor signaling activates SMADs|9606|false","R-HSA-2173795|Downregulation of SMAD2/3:SMAD4 transcriptional activity|9606|false","R-HSA-2173796|SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription|9606|false","R-HSA-3304356|SMAD2/3 Phosphorylation Motif Mutants in Cancer|9606|true","R-HSA-3311021|SMAD4 MH2 Domain Mutants in Cancer|9606|true","R-HSA-3315487|SMAD2/3 MH2 Domain Mutants in Cancer|9606|true","R-HSA-3656532|TGFBR1 KD Mutants in Cancer|9606|true","R-HSA-5689880|Ub-specific processing proteases|9606|false","R-HSA-8941855|RUNX3 regulates CDKN1A transcription|9606|false","R-HSA-8952158|RUNX3 regulates BCL2L11 (BIM) transcription|9606|false","R-HSA-9008059|Interleukin-37 signaling|9606|false","R-HSA-9013695|NOTCH4 Intracellular Domain Regulates Transcription|9606|false","R-HSA-9615017|FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes|9606|false","R-HSA-9617828|FOXO-mediated transcription of cell cycle genes|9606|false","R-HSA-9735871|SARS-CoV-1 targets host intracellular signalling and regulatory pathways|9606|true","R-HSA-9754189|Germ layer formation at gastrulation|9606|false","R-HSA-9796292|Formation of axial mesoderm|9606|false","R-HSA-9823730|Formation of definitive endoderm|9606|false","R-HSA-9839394|TGFBR3 expression|9606|false"]},{"input":"Q02297","source":"Q02297|Pro-neuregulin-1, membrane-bound isoform","targets":["R-HSA-1227986|Signaling by ERBB2|9606|false","R-HSA-1236394|Signaling by ERBB4|9606|false","R-HSA-1250196|SHC1 events in ERBB2 signaling|9606|false","R-HSA-1250342|PI3K events in ERBB4 signaling|9606|false","R-HSA-1250347|SHC1 events in ERBB4 signaling|9606|false","R-HSA-1251985|Nuclear signaling by ERBB4|9606|false","R-HSA-1257604|PIP3 activates AKT signaling|9606|false","R-HSA-1306955|GRB7 events in ERBB2 signaling|9606|false","R-HSA-1358803|Downregulation of ERBB2:ERBB3 signaling|9606|false","R-HSA-1963640|GRB2 events in ERBB2 signaling|9606|false","R-HSA-1963642|PI3K events in ERBB2 signaling|9606|false","R-HSA-2219530|Constitutive Signaling by Aberrant PI3K in Cancer|9606|true","R-HSA-5673001|RAF/MAP kinase cascade|9606|false","R-HSA-6785631|ERBB2 Regulates Cell Motility|9606|false","R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling|9606|false","R-HSA-8847993|ERBB2 Activates PTK6 Signaling|9606|false","R-HSA-8863795|Downregulation of ERBB2 signaling|9606|false","R-HSA-9620244|Long-term potentiation|9606|false","R-HSA-9664565|Signaling by ERBB2 KD Mutants|9606|true","R-HSA-9665686|Signaling by ERBB2 TMD/JMD mutants|9606|true"]},{"input":"P04818","source":"P04818|Thymidylate synthase","targets":["R-HSA-499943|Interconversion of nucleotide di- and triphosphates|9606|false","R-HSA-69205|G1/S-Specific Transcription|9606|false"]},{"input":"P06241","source":"P06241|Tyrosine-protein kinase Fyn","targets":["R-HSA-114604|GPVI-mediated activation cascade|9606|false","R-HSA-1227986|Signaling by ERBB2|9606|false","R-HSA-1257604|PIP3 activates AKT signaling|9606|false","R-HSA-1433557|Signaling by SCF-KIT|9606|false","R-HSA-1433559|Regulation of KIT signaling|9606|false","R-HSA-164944|Nef and signal transduction|9606|true","R-HSA-202733|Cell surface interactions at the vascular wall|9606|false","R-HSA-2029481|FCGR activation|9606|false","R-HSA-210990|PECAM1 interactions|9606|false","R-HSA-2219530|Constitutive Signaling by Aberrant PI3K in Cancer|9606|true","R-HSA-2424491|DAP12 signaling|9606|false","R-HSA-2682334|EPH-Ephrin signaling|9606|false","R-HSA-2730905|Role of LAT2/NTAL/LAB on calcium mobilization|9606|false","R-HSA-373753|Nephrin family interactions|9606|false","R-HSA-375165|NCAM signaling for neurite out-growth|9606|false","R-HSA-389356|Co-stimulation by CD28|9606|false","R-HSA-389357|CD28 dependent PI3K/Akt signaling|9606|false","R-HSA-389359|CD28 dependent Vav1 pathway|9606|false","R-HSA-389513|Co-inhibition by CTLA4|9606|false","R-HSA-3928662|EPHB-mediated forward signaling|9606|false","R-HSA-3928663|EPHA-mediated growth cone collapse|9606|false","R-HSA-3928664|Ephrin signaling|9606|false","R-HSA-3928665|EPH-ephrin mediated repulsion of cells|9606|false","R-HSA-399954|Sema3A PAK dependent Axon repulsion|9606|false","R-HSA-399955|SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion|9606|false","R-HSA-399956|CRMPs in Sema3A signaling|9606|false","R-HSA-4420097|VEGFA-VEGFR2 Pathway|9606|false","R-HSA-5621480|Dectin-2 family|9606|false","R-HSA-5621575|CD209 (DC-SIGN) signaling|9606|false","R-HSA-5673001|RAF/MAP kinase cascade|9606|false","R-HSA-6811558|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling|9606|false","R-HSA-75892|Platelet Adhesion to exposed collagen|9606|false","R-HSA-8866376|Reelin signalling pathway|9606|false","R-HSA-912631|Regulation of signaling by CBL|9606|false","R-HSA-9664323|FCGR3A-mediated IL10 synthesis|9606|true","R-HSA-9664422|FCGR3A-mediated phagocytosis|9606|true","R-HSA-9670439|Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants|9606|true","R-HSA-9680350|Signaling by CSF1 (M-CSF) in myeloid cells|9606|false","R-HSA-9706374|FLT3 signaling through SRC family kinases|9606|false","R-HSA-983695|Antigen activates B Cell Receptor (BCR) leading to generation of second messengers|9606|false","R-HSA-9856530|High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells|9606|false","R-HSA-418885|DCC mediated attractive signaling|9606|false","R-HSA-9032500|Activated NTRK2 signals through FYN|9606|false","R-HSA-9032759|NTRK2 activates RAC1|9606|false","R-HSA-9766229|Degradation of CDH1|9606|false"]},{"input":"P61812","source":"P61812|Transforming growth factor beta-2 proprotein","targets":["R-HSA-114608|Platelet degranulation |9606|false","R-HSA-2129379|Molecules associated with elastic fibres|9606|false","R-HSA-2173789|TGF-beta receptor signaling activates SMADs|9606|false","R-HSA-3000178|ECM proteoglycans|9606|false","R-HSA-9839389|TGFBR3 regulates TGF-beta signaling|9606|false"]}]}